CalciMedica, Historical Balance Sheet

CALC Stock

2.78 0.03 1.07%

Trend analysis of CalciMedica, Common Stock balance sheet accounts such as Other Current Liab of 3.1 M, Total Current Liabilities of 4.9 M or Total Stockholder Equity of 7.7 M provides information on CalciMedica, Common's total assets, liabilities, and equity, which is the actual value of CalciMedica, Common Stock to its prevalent stockholders. By breaking down trends over time using CalciMedica, Common balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining CalciMedica, Common Stock latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether CalciMedica, Common Stock is a good buy for the upcoming year.

CalciMedica, Common Inventory

(36,855)

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CalciMedica, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About CalciMedica, Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of CalciMedica, Common Stock at a specified time, usually calculated after every quarter, six months, or one year. CalciMedica, Common Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of CalciMedica, Common and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which CalciMedica, currently owns. An asset can also be divided into two categories, current and non-current.

CalciMedica, Common Balance Sheet Chart

At present, CalciMedica, Common's Total Current Liabilities is projected to decrease significantly based on the last few years of reporting. The current year's Accounts Payable is expected to grow to about 1.9 M, whereas Total Assets are forecasted to decline to about 11.6 M.

Total Assets Total Stockholder Equity Property Plant And Equipment Net Net Debt Accounts Payable

Total Assets

Total assets refers to the total amount of CalciMedica, Common assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in CalciMedica, Common Stock books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Accounts Payable

An accounting item on the balance sheet that represents CalciMedica, Common obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of CalciMedica, Common Stock are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most accounts from CalciMedica, Common's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into CalciMedica, Common Stock current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CalciMedica, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	3.5M	1.7M	2.5M	3.1M
Total Assets	69.1M	39.7M	12.2M	11.6M

Other Current Liab Total Assets

CalciMedica, Common balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Investments	Net Invested Capital	Property Plant And Equipment Gross	Capital Stock	Net Working Capital	Current Deferred Revenue	Short Term Debt	Common Stock	Net Receivables
Total Assets		0.33	0.17	1.0	0.4	-0.84	-0.48	-0.08	0.84	-0.24	-0.54	1.0	-0.26	0.94	0.71	0.17	1.0	0.93	0.72	-0.07	-0.52	0.96	-0.19	-0.16	0.27	-0.15
Other Current Liab	0.33		0.96	0.25	0.58	-0.31	0.16	0.62	0.31	0.31	0.09	0.3	-0.25	0.09	-0.02	0.96	0.3	0.22	-0.15	0.39	0.25	0.18	-0.41	-0.41	0.23	-0.43
Total Current Liabilities	0.17	0.96		0.09	0.53	-0.31	0.3	0.81	0.3	0.46	0.31	0.14	-0.34	-0.1	-0.27	1.0	0.13	0.07	-0.34	0.46	0.42	0.04	-0.42	-0.44	0.3	-0.44
Total Stockholder Equity	1.0	0.25	0.09		0.35	-0.82	-0.51	-0.15	0.82	-0.28	-0.57	1.0	-0.23	0.96	0.74	0.09	1.0	0.93	0.76	-0.11	-0.56	0.97	-0.15	-0.12	0.24	-0.12
Property Plant And Equipment Net	0.4	0.58	0.53	0.35		-0.49	0.53	0.22	0.49	0.72	0.39	0.33	-0.8	0.38	-0.1	0.53	0.34	0.6	-0.29	0.87	0.52	0.49	-0.96	-0.95	0.73	-0.92
Net Debt	-0.84	-0.31	-0.31	-0.82	-0.49		0.11	-0.27	-1.0	-0.14	0.1	-0.82	0.58	-0.74	-0.3	-0.31	-0.82	-0.83	-0.39	-0.2	0.15	-0.88	0.39	0.39	-0.51	0.34
Retained Earnings	-0.48	0.16	0.3	-0.51	0.53	0.11		0.31	-0.11	0.88	0.87	-0.53	-0.53	-0.42	-0.7	0.3	-0.53	-0.22	-0.88	0.85	0.93	-0.31	-0.7	-0.73	0.39	-0.69
Accounts Payable	-0.08	0.62	0.81	-0.15	0.22	-0.27	0.31		0.27	0.51	0.55	-0.09	-0.4	-0.38	-0.61	0.81	-0.11	-0.19	-0.48	0.34	0.51	-0.15	-0.24	-0.28	0.38	-0.25
Cash	0.84	0.31	0.3	0.82	0.49	-1.0	-0.11	0.27		0.15	-0.09	0.82	-0.59	0.74	0.29	0.3	0.82	0.83	0.38	0.21	-0.14	0.88	-0.4	-0.39	0.52	-0.34
Non Current Assets Total	-0.24	0.31	0.46	-0.28	0.72	-0.14	0.88	0.51	0.15		0.92	-0.3	-0.83	-0.27	-0.75	0.46	-0.3	0.01	-0.83	0.95	0.95	-0.09	-0.87	-0.89	0.74	-0.82
Non Currrent Assets Other	-0.54	0.09	0.31	-0.57	0.39	0.1	0.87	0.55	-0.09	0.92		-0.58	-0.65	-0.57	-0.93	0.31	-0.58	-0.33	-0.93	0.77	0.96	-0.39	-0.61	-0.64	0.57	-0.57
Cash And Short Term Investments	1.0	0.3	0.14	1.0	0.33	-0.82	-0.53	-0.09	0.82	-0.3	-0.58		-0.21	0.93	0.73	0.14	1.0	0.91	0.76	-0.14	-0.57	0.95	-0.12	-0.09	0.22	-0.09
Common Stock Shares Outstanding	-0.26	-0.25	-0.34	-0.23	-0.8	0.58	-0.53	-0.4	-0.59	-0.83	-0.65	-0.21		-0.22	0.42	-0.34	-0.21	-0.49	0.4	-0.83	-0.62	-0.42	0.89	0.89	-0.94	0.8
Other Current Assets	0.94	0.09	-0.1	0.96	0.38	-0.74	-0.42	-0.38	0.74	-0.27	-0.57	0.93	-0.22		0.79	-0.1	0.94	0.96	0.75	-0.06	-0.55	0.97	-0.21	-0.17	0.22	-0.18
Other Stockholder Equity	0.71	-0.02	-0.27	0.74	-0.1	-0.3	-0.7	-0.61	0.29	-0.75	-0.93	0.73	0.42	0.79		-0.27	0.74	0.59	0.92	-0.53	-0.87	0.62	0.32	0.36	-0.4	0.32
Total Liab	0.17	0.96	1.0	0.09	0.53	-0.31	0.3	0.81	0.3	0.46	0.31	0.14	-0.34	-0.1	-0.27		0.13	0.07	-0.34	0.46	0.42	0.05	-0.42	-0.44	0.3	-0.44
Total Current Assets	1.0	0.3	0.13	1.0	0.34	-0.82	-0.53	-0.11	0.82	-0.3	-0.58	1.0	-0.21	0.94	0.74	0.13		0.91	0.76	-0.13	-0.57	0.95	-0.13	-0.1	0.22	-0.09
Short Term Investments	0.93	0.22	0.07	0.93	0.6	-0.83	-0.22	-0.19	0.83	0.01	-0.33	0.91	-0.49	0.96	0.59	0.07	0.91		0.55	0.2	-0.3	0.99	-0.46	-0.43	0.47	-0.41
Net Invested Capital	0.72	-0.15	-0.34	0.76	-0.29	-0.39	-0.88	-0.48	0.38	-0.83	-0.93	0.76	0.4	0.75	0.92	-0.34	0.76	0.55		-0.7	-0.96	0.63	0.49	0.52	-0.33	0.48
Property Plant And Equipment Gross	-0.07	0.39	0.46	-0.11	0.87	-0.2	0.85	0.34	0.21	0.95	0.77	-0.14	-0.83	-0.06	-0.53	0.46	-0.13	0.2	-0.7		0.86	0.08	-0.96	-0.97	0.74	-0.93
Capital Stock	-0.52	0.25	0.42	-0.56	0.52	0.15	0.93	0.51	-0.14	0.95	0.96	-0.57	-0.62	-0.55	-0.87	0.42	-0.57	-0.3	-0.96	0.86		-0.39	-0.7	-0.73	0.54	-0.68
Net Working Capital	0.96	0.18	0.04	0.97	0.49	-0.88	-0.31	-0.15	0.88	-0.09	-0.39	0.95	-0.42	0.97	0.62	0.05	0.95	0.99	0.63	0.08	-0.39		-0.34	-0.31	0.41	-0.3
Current Deferred Revenue	-0.19	-0.41	-0.42	-0.15	-0.96	0.39	-0.7	-0.24	-0.4	-0.87	-0.61	-0.12	0.89	-0.21	0.32	-0.42	-0.13	-0.46	0.49	-0.96	-0.7	-0.34		1.0	-0.8	0.95
Short Term Debt	-0.16	-0.41	-0.44	-0.12	-0.95	0.39	-0.73	-0.28	-0.39	-0.89	-0.64	-0.09	0.89	-0.17	0.36	-0.44	-0.1	-0.43	0.52	-0.97	-0.73	-0.31	1.0		-0.79	0.95
Common Stock	0.27	0.23	0.3	0.24	0.73	-0.51	0.39	0.38	0.52	0.74	0.57	0.22	-0.94	0.22	-0.4	0.3	0.22	0.47	-0.33	0.74	0.54	0.41	-0.8	-0.79		-0.8
Net Receivables	-0.15	-0.43	-0.44	-0.12	-0.92	0.34	-0.69	-0.25	-0.34	-0.82	-0.57	-0.09	0.8	-0.18	0.32	-0.44	-0.09	-0.41	0.48	-0.93	-0.68	-0.3	0.95	0.95	-0.8

Click cells to compare fundamentals

CalciMedica, Common Account Relationship Matchups

CalciMedica, Common balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	40.7M	101.8M	69.1M	39.7M	12.2M	11.6M
Other Current Liab	7.6M	4.5M	3.5M	1.7M	2.5M	3.1M
Total Current Liabilities	12.3M	7.0M	4.1M	3.7M	4.0M	4.9M
Total Stockholder Equity	28.4M	94.8M	65.0M	36.0M	8.2M	7.7M
Property Plant And Equipment Net	2.0M	1.9M	2.0M	195K	167K	158.7K
Net Debt	(15.9M)	(33.4M)	(13.4M)	(17.1M)	(5.5M)	(5.8M)
Retained Earnings	(105.8M)	(133.4M)	(169.2M)	(204.8M)	(146.1M)	(153.4M)
Accounts Payable	4.6M	2.5M	527K	2.9M	1.4M	1.9M
Cash	15.9M	33.4M	13.4M	17.3M	5.5M	5.3M
Non Current Assets Total	4.4M	2.6M	2.0M	1.6M	580K	551K
Non Currrent Assets Other	2.4M	580K	29K	1.4M	413K	392.4K
Cash And Short Term Investments	36.0M	95.0M	63.7M	39.1M	11.2M	10.7M
Common Stock Shares Outstanding	1.0M	472.7K	1.5M	1.5M	4.5M	4.7M
Liabilities And Stockholders Equity	40.7M	101.8M	69.1M	39.7M	12.2M	11.6M
Other Current Assets	315K	4.2M	3.4M	1.0M	367K	348.7K
Other Stockholder Equity	2.9M	228.2M	234.2M	40.4M	154.2M	121.4M
Total Liab	12.3M	7.0M	4.1M	3.7M	4.0M	4.9M
Total Current Assets	36.3M	99.2M	67.1M	39.7M	11.6M	11.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether CalciMedica, Common Stock offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CalciMedica, Common's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Calcimedica, Common Stock Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Calcimedica, Common Stock Stock:

How To Invest In CalciMedica,

Details

Is CalciMedica, Stock a good investment?

Details

What is CalciMedica, Common's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CalciMedica, Common. If investors know CalciMedica, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CalciMedica, Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.11)

Return On Assets

(0.65)

Return On Equity

(0.84)

The market value of CalciMedica, Common Stock is measured differently than its book value, which is the value of CalciMedica, that is recorded on the company's balance sheet. Investors also form their own opinion of CalciMedica, Common's value that differs from its market value or its book value, called intrinsic value, which is CalciMedica, Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CalciMedica, Common's market value can be influenced by many factors that don't directly affect CalciMedica, Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between CalciMedica, Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if CalciMedica, Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CalciMedica, Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

CalciMedica, Historical Balance Sheet

CalciMedica, Common Inventory

(36,855)

About CalciMedica, Balance Sheet Analysis

CalciMedica, Common Balance Sheet Chart

Total Assets

Total Stockholder Equity

Property Plant And Equipment Net

Net Debt

Accounts Payable

CalciMedica, Common balance sheet Correlations

CalciMedica, Common Account Relationship Matchups

High Positive Relationship

High Negative Relationship

CalciMedica, Common balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Total Stockholder Equity

Cash	- 1.0	Net Debt
Short Term Debt	- 0.97	Property Plant And Equipment Gross
Current Deferred Revenue	- 0.96	Property Plant And Equipment Gross
Capital Stock	- 0.96	Net Invested Capital
Current Deferred Revenue	- 0.96	Property Plant And Equipment Net
Short Term Debt	- 0.95	Property Plant And Equipment Net